Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

8.765 +0.145 (+1.68%)
Streaming Delayed Price Updated: 12:14 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 Next >
RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
Via Benzinga
Preview: Bausch Health Companies's Earnings
Via Benzinga
A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target
Fahmi Quadir, featured in the Netflix series "Dirty Money" for her success in predicting and betting on the collapse of Valeant ... 
Via Benzinga
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Bausch Health Stock Is Jumping Today
Investors appear to be shaking off their concerns about Bausch Health's CFO turnover. 
Via The Motley Fool
Why Shares of Bausch Health Jumped on Friday
Global investment powerhouse KKR will be providing the healthcare company with increased liquidity. 
Via The Motley Fool
Wall Street On Track For Another Win Amid Interest Rate Buzz
Wall Street is looking to extend a winning streak, as investors prepare for the Federal Reserve's latest interest rate decision. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
The U.S. 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Via Benzinga
Why Bausch Health Companies Stock Is Tanking Today
The never-ending saga over generic Xifaxan is weighing on the drugmaker's stock today. 
Via The Motley Fool
Why Shares of Bausch Health Soared Wednesday
The company won a big patent fight with a generic-drug maker. 
Via The Motley Fool
Steelcase, Western Digital, Bausch Health And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly higher on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Shares of Bausch Health Companies Fell Tuesday
The company announced a chief financial officer transition plan. 
Via The Motley Fool
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost. 
Via Benzinga
Why Bausch Health Stock Is Tumbling Today
Bausch Health Companies Inc (NYSE: BHC) reported Q1 FY23 revenues of $1.94 billion, up 1% Y/Y, up 4% organic basis, missing the consensus  
Via Benzinga
Recap: Bausch Health Companies Q1 Earnings
Via Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
Breather For Carl Icahn: Revised Loan Agreements and Recovery Strategy Post Short-Seller Attack
Activist investor Carl Icahn has been struggling to recover after a short-seller attack led to a 40% drop in his investment company's shares, Icahn Enterprises L.P. (NASDAQ: IEP), alarming major banks... 
Via Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Bausch Health Options Traders: Stock Will Remain Below This Level Through July Expiration
Bausch Health Companies Inc. (NYSE: BHC) shares rose sharply on Wednesday. 
Via Benzinga
US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'
With so much going on in the banking space, sentiment continues to remain jittery. The index futures point to a mixed opening on Thursday, as the tech space exuded optimism ahead of Apple, Inc.’s... 
Via Benzinga
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44. 
Via Benzinga
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a  
Via Benzinga
Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up
The company’s adjusted earnings per share of $1.02, which beat the Zacks Consensus Estimate of 92 cents and our estimate of 84 cents but decreased from $1.29 reported in the year-ago quarter. 
Via Talk Markets
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.